Volume 2015, Issue 1 780903
Letter to the Editor
Open Access

Comment on “Renal Protective Effect of Sirtuin 1”

Kultigin Turkmen

Corresponding Author

Kultigin Turkmen

Division of Nephrology, Department of Internal Medicine, Meram School of Medicine, Konya Necmettin Erbakan University, 42090 Konya, Turkey konya.edu.tr

Search for more papers by this author
First published: 20 September 2015
Citations: 2
Academic Editor: Daisuke Koya

I read the review article written by Dong et al. [1] regarding the renal effects of sirtuin 1 with great interest. The authors described the harmful effects of advanced glycation end products on podocyte apoptosis via increasing Bcl-2 protein secondary to forkhead box O4 (FOXO4) acetylation in diabetes mellitus according to Chung et al.’ findings. However, Chuang et al. [2] demonstrated that the apoptosis of podocyte was associated with the expression of a proapoptosis gene, Bcl-2-like 11 (Bcl2l11), not antiapoptotic Bcl-2. To date, a total of 25 Bcl-2 related genes have been identified. Among them, Bcl-2, Bcl-xL, and Bcl-w are antiapoptotic; however, BAD, Bax, Bak, and Bcl2l11 are proapoptotic [3]. Hence, researchers should consider this important knowledge to avoid misunderstanding.

Conflict of Interests

The author declares that there is no conflict of interests regarding the publication of this paper.

    The full text of this article hosted at iucr.org is unavailable due to technical difficulties.